Skip to main content
Livermore
Livermore
ZHEN

Natixis Advisors, L.P.

SEC CIK
0001018331
Latest filing
Aug 14, 2026

IONS holding history

Ionis Pharmaceuticals Inc in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IONS overviewAll 13F holders of IONSFull Q2 2026 holdings

Shares (Q2 2026)
44,728
Value
$3.55M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of IONS by Natixis Advisors, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202644,728$3.55M<0.1%+21,007+88.6%AddedHolders
Q1 202623,721$1.78M<0.1%+1,830+8.4%AddedHolders
Q4 202521,891$1.73M<0.1%+21,891NewHolders
Q1 20250$00.0%−14,313−100.0%Sold outHolders
Q4 202414,313$500.0K<0.1%−6,767−32.1%ReducedHolders
Q3 202421,080$844.0K<0.1%−2,324−9.9%ReducedHolders
Q2 202423,404$1.11M<0.1%+376+1.6%AddedHolders
Q1 202423,028$998.0K<0.1%+5,715+33.0%AddedHolders
Q4 202317,313$875.0K<0.1%+1,394+8.8%AddedHolders
Q3 202315,919$722.0K<0.1%−279−1.7%ReducedHolders
Q2 202316,198$665.0K<0.1%+122+0.8%AddedHolders
Q1 202316,076$575.0K<0.1%−127−0.8%ReducedHolders
Q4 202216,203$612.0K<0.1%+385+2.4%AddedHolders
Q3 202215,818$700.0K<0.1%−12−0.1%ReducedHolders
Q2 202215,830$586.0K<0.1%−31−0.2%ReducedHolders
Q1 202215,861$587.0K<0.1%−34−0.2%ReducedHolders
Q4 202115,895$484.0K<0.1%−1,833−10.3%ReducedHolders
Q3 202117,728$595.0K<0.1%−1,136−6.0%ReducedHolders
Q2 202118,864$752.0K<0.1%−1,740−8.4%ReducedHolders
Q1 202120,604$926.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.